New medication check in Wiener Neustadt: precise therapy through genetic testing

Transparenz: Redaktionell erstellt und geprüft.
Veröffentlicht am

New in the Fischapark Pharmacy: The “Permedio Medicine Check” enables individual therapies based on DNA analyses. Optimal drug tolerance and effectiveness for patients in Wiener Neustadt!

New medication check in Wiener Neustadt: precise therapy through genetic testing

There is now an exciting innovation for patients in Wiener Neustadt: the “Permedio Medicine Check” is offered in the Fischapark Pharmacy. This innovative genetic test, provided by the “Permedio” health center in Neunkirchen, enables tailor-made therapy based on individual DNA. The aim is to increase the effectiveness of medications, reduce side effects and identify possible interactions.

Antonia Kern, the owner of the Fischapark Pharmacy, explained: "With the 'PermedioMedicineCheck' we can use a one-off genetic test to determine how a patient reacts to certain medications. Using the individual DNA, we can find out which medications are best tolerated and most effective. This allows doctors to prescribe the right medications and ensure that every patient receives the best possible therapy - a lifelong benefit." This means that every patient has the chance to benefit from individually tailored medication.

How the medication check works

The process begins with a pharmacogenetic test. This involves taking a saliva sample to analyze genetic information that provides information about how the body can metabolize medications. This research is particularly important because genetic differences between people have a significant impact on how they respond to different medications.

Following the genetic analysis, other factors such as side effects, effectiveness and possible interactions are also considered. The aim is to ensure comprehensive and individually tailored treatment for each patient. In order to use the latest findings in drug and genetics research, patients have access to an online tool. There they can compare their genetic data with the prescribed medication. If necessary, the medication can be adjusted immediately in collaboration with the treating doctor.

Permedio International GmbH is pleased about this cooperation with Fischapark Apotheke. Managing director Katharina Schneider emphasizes: "We are very grateful that Antonia Kern has included the 'Permedio Medicine Check' in her range. The Fischapark Pharmacy has an excellent reputation and our collaboration will benefit many people in the region." Schneider also points out that incorrect medication and its side effects are among the most common causes of death. It is therefore essential to use a genetic test to determine the appropriate medication to ensure optimal treatment. This is a significant step towards improving patient care in the region.

For further information on this topic and the exact procedure of the “Permedio Medicine Check”, the Fischapark Pharmacy offers comprehensive advice. The initiative could make a significant difference in the region's healthcare system by providing individualized and safe therapies for patients. More about this can be found right here on www.noen.at.